Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= MAT2A ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: MAT2A * **<color #00a2e8>Official Name</color>**: methionine adenosyltransferase 2A * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4144|4144]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P31153|P31153]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=MAT2A&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAT2A|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/601468|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: The protein encoded by this gene catalyzes the production of S-adenosylmethionine (AdoMet) from methionine and ATP. AdoMet is the key methyl donor in cellular processes. [provided by RefSeq, Jun 2011]. * **<color #00a2e8>UniProt Summary</color>**: Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate. {ECO:0000269|PubMed:10644686, ECO:0000269|PubMed:23189196, ECO:0000269|PubMed:25075345}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |S-AdoMet synt C| |S-AdoMet synt N| |S-AdoMet synt M| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |methionine adenosyltransferase complex| |methionine adenosyltransferase activity| |S-adenosylmethionine biosynthetic process| |protein hexamerization| |S-adenosylmethionine metabolic process| |one-carbon metabolic process| |cellular response to leukemia inhibitory factor| |response to leukemia inhibitory factor| |protein heterooligomerization| |coenzyme biosynthetic process| |sulfur compound biosynthetic process| |cofactor biosynthetic process| |coenzyme metabolic process| |methylation| |sulfur compound metabolic process| |cofactor metabolic process| |drug metabolic process| |protein complex oligomerization| |cellular response to cytokine stimulus| |identical protein binding| |response to cytokine| |ATP binding| |protein-containing complex assembly| |small molecule metabolic process| |protein-containing complex subunit organization| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|-2.6| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.82| |[[:results:exp134|MS023 2μM R03 exp134]]|-1.82| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|-1.82| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.73| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.7| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.7| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.71| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.72| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|1.77| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.77| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.79| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.81| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.82| |[[:results:exp16|DABN 2μM R00 exp16]]|1.84| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.85| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.9| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|1.93| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|2.02| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|2.09| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|2.12| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.488| |[[:human genes:p:polr2j3|POLR2J3]]|0.473| |[[:human genes:c:cdca3|CDCA3]]|0.471| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.454| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.444| |[[:human genes:c:ccna2|CCNA2]]|0.44| |[[:human genes:d:dtl|DTL]]|0.439| |[[:human genes:t:tceb3c|TCEB3C]]|0.437| |[[:human genes:t:tbc1d3c|TBC1D3C]]|0.435| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.434| |[[:human genes:t:tfip11|TFIP11]]|0.428| |[[:human genes:p:psmd3|PSMD3]]|0.426| |[[:human genes:m:med17|MED17]]|0.425| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.421| |[[:human genes:r:rad21|RAD21]]|0.417| |[[:human genes:p:plk1|PLK1]]|0.416| |[[:human genes:c:cdc45|CDC45]]|0.415| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.414| |[[:human genes:f:fam20a|FAM20A]]|0.412| |[[:human genes:p:polr2a|POLR2A]]|0.412| |[[:human genes:d:dock6|DOCK6]]|0.412| |[[:human genes:s:ssh2|SSH2]]|0.409| |[[:human genes:d:ddtl|DDTL]]|0.409| |[[:human genes:c:chd4|CHD4]]|0.407| |[[:human genes:p:psmc6|PSMC6]]|0.405| |[[:human genes:c:cgb2|CGB2]]|0.405| |[[:human genes:p:psmb1|PSMB1]]|0.401| |[[:human genes:c:ccdc94|CCDC94]]|0.401| |[[:human genes:t:tsg101|TSG101]]|0.401| |[[:human genes:c:c14orf93|C14orf93]]|0.4| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 494/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|20/28| |blood|24/28| |bone|12/26| |breast|28/33| |central nervous system|25/56| |cervix|2/4| |colorectal|12/17| |esophagus|10/13| |fibroblast|0/1| |gastric|11/16| |kidney|14/21| |liver|9/20| |lung|55/75| |lymphocyte|13/16| |ovary|14/26| |pancreas|20/24| |peripheral nervous system|9/16| |plasma cell|13/15| |prostate|1/1| |skin|17/24| |soft tissue|5/9| |thyroid|1/2| |upper aerodigestive|15/22| |urinary tract|14/29| |uterus|3/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 496 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 9.71 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='MAT2A Expression in NALM6 Cells: 9.71'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1